Rongbiao Pi

600 Tianhe Road
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

A Niacin-α-Lipoic Acid Hybrid Ameliorates Alzheimer's Disease Pathology in Mouse Models.

A Niacin-α-Lipoic Acid Hybrid Ameliorates Alzheimer's Disease Pathology in Mouse Models.

Journal: ACS pharmacology & translational science

Published: March 18, 2026

A novel derivative of rhein overcomes temozolomide resistance in glioblastoma by regulating SOX9 through m6A methylation.

A novel derivative of rhein overcomes temozolomide resistance in glioblastoma by regulating SOX9 through m6A methylation.

Journal: Brain research

Published: March 21, 2025

Masitinib attenuates neuropathological changes in acrolein-induced sAD mouse model via NF-κB/NLRP3/Caspase-1 signaling pathway.

Masitinib attenuates neuropathological changes in acrolein-induced sAD mouse model via NF-κB/NLRP3/Caspase-1 signaling pathway.

Journal: Neuroscience letters

Published: March 17, 2025

Design and characterization of N-oxide cinnamanilide derivative PX5-9: Improved solubility and BDNF upregulation.

Design and characterization of N-oxide cinnamanilide derivative PX5-9: Improved solubility and BDNF upregulation.

Journal: Bioorganic & medicinal chemistry letters

Published: February 26, 2025

In situ chemical reprogramming of astrocytes into neurons: A new hope for the treatment of central neurodegenerative diseases?

In situ chemical reprogramming of astrocytes into neurons: A new hope for the treatment of central neurodegenerative diseases?

Journal: European journal of pharmacology

Published: May 16, 2024

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease.

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease.

Journal: Mini reviews in medicinal chemistry

Published: May 15, 2024

Acrolein Induces Retinal Abnormalities of Alzheimer's Disease in Mice.

Acrolein Induces Retinal Abnormalities of Alzheimer's Disease in Mice.

Journal: International journal of molecular sciences

Published: July 18, 2023

Correction to "Design, Synthesis, and Biological Evaluation of Novel Multifunctional Rolipram-Tranilast Hybrids As Potential Treatment for Traumatic Brain Injury".

Correction to "Design, Synthesis, and Biological Evaluation of Novel Multifunctional Rolipram-Tranilast Hybrids As Potential Treatment for Traumatic Brain Injury".

Journal: ACS chemical neuroscience

Published: July 07, 2023

Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer's disease.

Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer's disease.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 25, 2023

Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway.

Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway.

Journal: Aging cell

Published: January 13, 2022

PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway.

PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway.

Journal: European journal of pharmacology

Published: November 23, 2021

L-F001, a Multifunctional Fasudil-Lipoic Acid Dimer Prevents RSL3-Induced Ferroptosis via Maintaining Iron Homeostasis and Inhibiting JNK in HT22 Cells.

L-F001, a Multifunctional Fasudil-Lipoic Acid Dimer Prevents RSL3-Induced Ferroptosis via Maintaining Iron Homeostasis and Inhibiting JNK in HT22 Cells.

Journal: Frontiers in cellular neuroscience

Published: October 15, 2021

Showing 1-12 of 78

Last Updated: 09/26/2026